12th Q&A With Dr. Bernstein
Can Januvia Trigger Cancer Symptoms? I have been a type 2 diabetic for more than 10 years, and have been
Read more
Fda
FDA Panelists Vote to Ease Up on Avandia
A significant majority-20 of 26 members attending a combined meeting of FDA advisory committees-has voted to modify or remove the
Read more
Ready for a Diabetes Drug Tune-Up?
People with diabetes know the score. We’ve all seen “revolutionary” drugs and treatments introduced with fanfare, and we know that
Read more
Smaller, Lighter OmniPod Earns FDA Approval
The FDA recently approved the next-generation OmniPod from Insulet, giving people with insulin-dependent diabetes an even less invasive way to
Read more
Could Pig Worms Lead to the Cure for Type 1?
Research into a cure for type 1 diabetes proceeds on several fronts. One interesting approach is seeking ways to manipulate
Read more
Tandem Announces Two Partnerships
Tandem Diabetes Care, Inc. has teamed with Dexcom to expand an existing partnership to include development of Dexcom’s latest continuous
Read more
Type 2: FDA OKs Canagliflozin But Has Concerns About Heart Risk
In a 10-5 vote, an FDA panel has recommended that the agency approve the marketing of Johnson & Johnson’s InvokanaTM
Read more
Lilly Says Its New Injectible Outperforms Three Popular Diabetes Drugs
Good news for Eli Lilly & Co., as well as for type 2s who appreciate the addition of new drugs
Read more
FDA Approves Dexcom’s G4
The FDA has approved U.S. sales of Dexcom’s G4TM PLATINUM continuous glucose monitor. The San Diego-based manufacturer said it is
Read more
Oral Agents for Lowering Blood Sugar in Type 2 Diabetes
Part 1: Sulfonylureas and Meglitinides
Read more
Needle-Free CGM Could Be Available in 2013
Philadelphia-based Echo Therapeutics plans to introduce a needle-free continuous glucose monitoring system to the US market in 2013, pending FDA
Read more